| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.45 | 0.005 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.005 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.092 | 0.006 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.007 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.097 | 0.007 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.48 | 0.008 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.008 |